Brief: NanoRepro Due Diligence On Viromed Group Expected To Be Completed On 22 December 2021
Nov 9 (Reuters) - NanoRepro AG NN6G.DE :
* DUE DILIGENCE ON POSSIBLE INTEGRATION OF BUSINESS
ACTIVITIES OF
THE VIROMED GROUP EXPECTED TO BE COMPLETED BY THE ANNUAL GENERAL
MEETING ON 22 DECEMBER 2021
Source text for Eikon: ID:nEQ2BVdsKa
Further company coverage: NN6G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on NanoRepro AG
See all newsBrief: NanoRepro Enters Market For Diabetes Diagnostics
Brief: NanoRepro FY Profit After Taxes At EUR 29.7 Mln
Brief: Nanorepro Announces Talks With Viromed Group On Integration Of Individual Business Units Terminated For The Time Being
Brief: NanoRepro Completes Comparative Study, Says Its Tests Detect Omicron
Brief: NanoRepro - Change In Forecast 2021 And Outlook 2022 With Dividend